Position in NKTR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$47,819
-$1,466 QoQ
Shares Held
685
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#201
of 240 holders
Holding Since
Mar 2022
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NKTR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NATIXIS holds $65,699,213 across 42 Biotechnology names. NKTR ranks #35 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
59,095 | $29,354,259 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
109,905 | $9,556,239 | |
| 3 | EXEL |
Exelixis, Inc.
|
121,041 | $6,585,840 | |
| 4 | MRNA |
Moderna, Inc.
|
66,370 | $4,647,891 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
6,599 | $4,114,740 | |
| 6 | CAI |
Caris Life Sciences, Inc.
|
124,716 | $2,222,439 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
8,467 | $1,585,699 | |
| 8 | PTGX |
Protagonist Therapeutics, Inc
|
7,776 | $953,182 |
All Filings in NKTR
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $47,819 | 685 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $49,285 | 685 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $28,961 | 685 | Shares | Sole | 2026-02-13 | |
| 2022-03-31 | $254,343 | 47,188 | Shares | Sole | 2022-05-13 | |
| No filing history on record for this holder in this stock. | ||||||